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The endothelium is a major regulator of vascular homeostasis and exerts a number  
of vasoprotective effects, including production of vasodilating agents, suppression of smooth 
muscle cell growth, or inhibition of inflammatory responses. Most of these effects are mediated 
by nitric oxide (NO), the most effective endogenous vasodilator. Decreased NO production  
or its activity is a hallmark of endothelial dysfunction leading to an impaired  
endothelial-dependent vasodilation. Endothelial dysfunction is the first and key step in  
the development of atherosclerosis and can be detected before structural changes in the vessel 
wall. Atherosclerosis is a complex inflammatory disease underlying many cardiovascular 
disorders including ischemic heart disease and represents the major cause of morbidity  
and mortality in developed countries. Statins are drugs of choice in the treatment of 
atherosclerosis and ischemic heart disease, which have been shown to reduce LDL cholesterol 
levels and modulate endothelial function with their pleiotropic effects. 
Mouse models are currently the most commonly used animal model in the field  
of atherosclerosis research. Atherosclerotic changes can be achieved in a relatively short time 
frame, especially due to easy genetic manipulations and dietary interventions. These changes 
are detectable at both morphological and functional levels. Signaling pathway of transforming 
growth factor  (TGF) has one of the most significant roles during these processes.  
The role of membrane endoglin (TGF receptor III, Eng), its soluble form and other 
members of TGF signaling pathway in the development of endothelial dysfunction in selected 
mouse models of atherosclerosis, was the key topic of manuscripts in this summary dissertation 
thesis. The main objective of this thesis was focused on the role of soluble endoglin (sEng)  
in the pathogenesis of endothelial dysfunction, especially because of increased sEng levels were 
detected in patients with hypercholesterolemia, atherosclerosis, arterial hypertension,  
and type II diabetes mellitus. 
To determine the role of sEng in the development of endothelial dysfunction, we used 
transgenic mouse model with high levels of human sEng in plasma (Sol-Eng+ high) and their 
age matched littermates with low plasma levels of human sEng (Sol-Eng+ low) as a control 
group. Both groups were fed high fat diet to induce hypercholesterolemia and thus simulate  
the pathophysiological basis in patients with atherosclerosis in clinical practice. Study results 
showed, that increased sEng levels combined with mild hypercholesterolemia develop 
endothelial dysfunction like phenotype characterized by significantly impaired vasodilation  
and vasoconstriction in aortas of Sol-Eng+ high mice. Combination of increased sEng levels 
and hypercholesterolemia led to decreased expression of all members Eng/Smad 2/3/eNOS 
signaling in aorta resulting in impaired eNOS-dependent vasodilation and the development  
of endothelial dysfunction. 
The next study was focused on the changes in membrane Eng expression and  
sEng levels during early development of endothelial dysfunction. We used two-month-old 
female apolipoprotein E and LDL receptor double deficient mice (ApoE-/-/LDLR-/-) and female 
C57BL/6J mice at the same age as a control group. Mice were fed chow diet and spontaneous 
development of hypercholesterolemia was expected in ApoE-/-/LDLR-/- group. Study outcomes 
demonstrated, that hypercholesterolemia is accompanied by increased sEng levels, 
proinflammatory state and a disruption of NO metabolism. Furthermore, the results suggest that 
hypercholesterolemia leads to a decrease in membrane Eng expression and all members of its 
signaling resulting in the development of endothelial dysfunction in ApoE-/-/LDLR-/- group. 
The role of sEng as a possible inducer of endothelial dysfunction, that contributes to  
the development of hypertension was evaluated at the myocardial level. Transgenic mouse 
model expressing human sEng was used (Sol-Eng+ high and Sol-Eng+ low group). Mice were 
fed either chow or high fat diet. We assessed the hypothesis that increased sEng levels may 
result in expression changes in TGF signaling (Eng, Smad proteins), in expression of markers 
reflecting heart remodeling (PDGF, Co11A1), and inflammatory markers (VCAM-1,  
ICAM-1). Study results did not demonstrate the significant impact of increased sEng levels  
on morphological structure of myocardium (profibrotic and degenerative cardiomyocyte 
changes), development of inflammation or influence of TGF signaling. 
 The results of the studies helped to clarify the role of both forms of endoglin in  
the development of endothelial dysfunction. Decreased membrane Eng expression accompanies 
the development of endothelial dysfunction in mouse aorta. It can be also concluded, that 
increased sEng levels can be considered as a risk factor of cardiovascular disease development. 
